Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity.

Cancer genomics & proteomics - 1 Jan 2026

Barlak Bengi Su Rumeysa, Iskender Banu

Abstract excerpt

BACKGROUND/AIM: Reprogramming somatic cells to an embryonic state opens a transformative pathway to convert cancer cells into benign ones. By delving into the changes that occur during this process, we can enhance our understanding of tumor development and unlock groundbreaking therapeutic strategies. In this study, we successfully reprogrammed the bladder cancer cell line using Yamanaka factors and conducted a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Cell Plasticity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cellular Reprogramming

Share to Epithelial-Mesenchymal Transition

Share to Neoplastic Stem Cells

Share to Phenotype

Share to Proteomics

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 41771576
DOI: 10.21873/cgp.20578
PMCID: PMC12951382

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity.PMID 41771576Read ↗

Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerSemantic proximity Read ↗

Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancerSemantic proximity Read ↗

Intrinsic higher potency of basal urothelial cells to intermediate and umbrella cells as the cell of origin for bladder cancerSemantic proximity Read ↗

Patient derived models of bladder cancer amplify tumor specific gene expression compared to surgical specimen while maintaining gene expression of molecular subtype and epithelial mesenchymal transition markersSemantic proximity Read ↗

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancerSemantic proximity Read ↗

Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial CarcinomaSemantic proximity Read ↗

Analysis of Secreted Proteins for the Study of Bladder Cancer Cell AggressivenessSemantic proximity Read ↗

Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells.Semantic proximity Read ↗

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapySemantic proximity Read ↗

Biological heterogeneity of putative bladder cancer stem‐like cell populations from human bladder transitional cell carcinoma samplesSemantic proximity Read ↗

Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.Semantic proximity Read ↗

Targeting neuropilin-1 and neutralizing interleukin-6 inhibits cancer stem cell formation in bladder cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.